Overview

Assessment of Fluticasone Propionate on Ocular Allergy Symptoms

Status:
Completed
Trial end date:
2013-02-01
Target enrollment:
Participant gender:
Summary
This study is designed to investigate the efficacy of fluticasone propionate (FP) on ocular symptoms associated with allergic rhinitis (AR).
Phase:
Phase 3
Details
Lead Sponsor:
GlaxoSmithKline
Treatments:
Fluticasone
Xhance